# US 2019/0240594 A1 · Channeled Fibers in Separation of Biologically Active Nanoparticles

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0240594 A1
- Document ID: US20190240594A1
- Status: Published application
- Kind: A1
- Application number: 16/267,579
- Filed: 2019-02-05
- Published: 2019-08-08
- Earliest claimed: 2018-02-05
- Assignees: Clemson University Research Foundation
- Applicants: Clemson University Research Foundation
- Inventors: R. KENNETH MARCUS; TERRI F. BRUCE; LEI WANG; SISI HUANG; TYLER Y. SLONECKI; RHONDA REIGERS POWELL
- Web page: https://patentgrep.com/patent/US20190240594A1

## CPC

- B01D 15/327: {with hydrophobic interaction}
- C07K 14/47: from mammals
- C12N 9/00: Enzymes; Proenzymes; Compositions thereof (preparations containing enzymes for cleaning teeth A61K8/66, A61Q11/00; medicinal preparations containing enzymes or proenzymes A61K38/43; enzyme containing detergent compositions C11D; {enzymes with nucleic acid structure, e.g. ribozymes, C12N15/113}); Processes for preparing, activating, inhibiting, separating or purifying enzymes (preparation of malt C12C1/00)
- C12N 15/10: Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34)
- C12N 15/1017: {by filtration, e.g. using filters, frits, membranes}
- G01N 1/405: {by adsorption or absorption}
- G01N 33/5005: {involving human or animal cells (immunoassay G01N33/56966; immunoassays of protozoa G01N33/56905; protozoa in screening assays C12Q1/025)}
- A61K 35/68: Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma
- B01J 20/262: {obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. obtained by polycondensation (macromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds per se C08G)}
- B01J 20/28023: {Fibres or filaments (fibres or filaments in the form of membranes B01J20/28038; B01J20/28007 takes precedence)}
- B01J 20/285: based on polymers
- B01J 20/286: Phases chemically bonded to a substrate, e.g. to silica or to polymers
- B01J 2220/54: Sorbents specially adapted for analytical or investigative chromatography
- B01D: SEPARATION (separating solids from solids by wet methods B03B, B03D; by pneumatic jigs or tables B03B; by other dry methods B07; magnetic or electrostatic separation of solid materials from solid materials or fluids, separation by high-voltage electric fields B03C; centrifuges, vortex apparatus B04; presses per se for squeezing-out liquid from liquid-containing material B30B9/02; treatment of water C02F, e.g. softening by ion-exchange C02F1/42; {arrangements of air intake cleaners in gas turbine plants F02C7/05} ; arrangements or mounting of filters in air-conditioning, air-humidification or ventilation F24F13/28)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS

## Abstract

A relatively fast, inexpensive, and non-destructive method for separation and isolation of biologically active nanoparticles is described. Methods include the use of solid phase separation medis such as channeled fibers in a hydrophobic interaction chromatography (HIC) protocol to isolate biologically active nanoparticles from other components of a mixture. Biologically active nanoparticles can include natural nanoparticles (e.g., exosomes, lysosomes, virus particles) as well as synthetic nanoparticles (liposomes, genetically modified virus particles, etc.)

## Claims

### Claim 1

A method for separating biologically active nanoparticles from a mixture comprising:
flowing a mobile phase through a fluid conduit having a first end and second end that is disposed opposite the first end, the mobile phase including a salt, the fluid conduit containing a solid phase, the solid phase defining a plurality of passages through the fluid conduit, the passages defining a cross sectional dimension of from about 1 micrometer to about 4 micrometers, the solid phase having a surface that is non-porous to nanoparticles and that has a critical surface tension of about 35 mJ/m2 or greater and a water contact angle of about 85° or less;
combining a mixture with the mobile phase, the mixture comprising biologically active nanoparticles, the biologically active nanoparticles adsorbing or binding to the surface of the solid phase as the mobile phase flows through the fluid conduit.

### Claim 2 (depends on 1)

The method of claim 1, further comprising following an adsorption or binding period, modifying the mobile phase, the biologically active nanoparticles releasing from the surface of the solid phase as the modified mobile phase flows through the fluid conduit, the method further comprising collecting the released biologically active nanoparticles.

### Claim 3 (depends on 2)

The method of claim 2, wherein at least following the adsorption or binding period, the mobile phase comprises an organic modifier.

### Claim 4 (depends on 2)

The method of claim 2, wherein the modification to the mobile phase comprises decreasing the concentration of the salt in the mobile phase.

### Claim 5 (depends on 1)

The method of claim 1, further comprising following an adsorption or binding period, binding a detectable label to the biologically active nanoparticles.

### Claim 6 (depends on 1)

The method of claim 1, further comprising following an adsorption or binding period, lysing the biologically active nanoparticles.

### Claim 7 (depends on 1)

The method of claim 1, the solid phase comprising a fiber that defines a plurality of co-linear channels on a surface of the fiber, the co-linear channels extending along an axial length of the fiber.

### Claim 8 (depends on 1)

The method of claim 1, wherein the biologically active nanoparticles comprise natural nanoparticles.

### Claim 9 (depends on 1)

The method of claim 1, wherein the biologically active nanoparticles comprise exosomes.

### Claim 10 (depends on 9)

The method of claim 9, wherein the mixture comprises multiple different types of biologically active nanoparticles, the method further comprising decreasing the salt concentration of the mobile phase to a first lower concentration and thence to a second lower concentration, wherein a first type of biologically active nanoparticles release from the surface of the fiber as the mobile phase comprising the first lower salt concentration flows through the fluid conduit and a second type of biologically active nanoparticles release from the surface of the fiber as the mobile phase comprising the second lower salt concentration flows through the fluid conduit.

### Claim 11 (depends on 10)

The method of claim 10, wherein the salt concentration is decreased gradually over a period of time.

### Claim 12 (depends on 1)

The method of claim 1, wherein the surface of the solid phase comprises a polymeric composition.

### Claim 13 (depends on 12)

The method of claim 12, wherein the polymeric composition comprises a polyethylene terephthalate or a nylon.

### Claim 14 (depends on 1)

The method of claim 1, wherein the mixture is derived from a biological source, or the mixture comprises a biological fluid, or the mixture comprises cell culture media.

### Claim 15 (depends on 1)

The method of claim 1, wherein the conduit exhibits a backing pressure of about 500 psi to about 1000 psi at a mobile phase flow rate of about 0.5 m L/min to about 3 mL/min through the conduit.

### Claim 16 (depends on 1)

The method of claim 1, the surface of the solid phase comprising a binding agent for the biologically active nanoparticles.

### Claim 17 (depends on 1)

The method of claim 1, the mobile phase including the salt in a concentration of from about 1 M to about 3 M.

### Claim 18 (depends on 1)

The method of claim 1, the mobile phase having a linear velocity through the conduit of about 50 mm/second or greater.

### Claim 19 (depends on 1)

The method of claim 1, wherein the solid phase comprises a bundle of aligned fibers or wherein the solid phase consists of a single fiber, or wherein the solid phase comprises a flat fiber or film including a plurality of channels linearly adjacent to one another.

### Claim 20 (depends on 1)

The method of claim 1, further comprising imaging the biologically active nanoparticles when they are adsorbed or bonded to the surface of the fiber.
